View in EDS HTML Full Text PDF Full Text

Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.

Saved in:
Bibliographic Details
Title: Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.
Authors: Huebner H; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Wimberger P; Department of Gynecology and Obstetrics, Carl Gustav Carus Faculty of Medicine and University Hospital, Dresden, TU 01307, Germany.; National Center for Tumor Diseases (NCT), Dresden 01307, Germany; German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Carl Gustav Carus Faculty of Medicine and University Hospital, Dresden, TU 01307, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden 01307, Germany.; German Cancer Consortium (DKTK), Dresden 01307, Germany; German Cancer Research Center (DKFZ), Heidelberg 69120, Germany., Laakmann E; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg 20246, Germany., Ruckhäberle E; Department of Gynecology and Obstetrics, CIO ABCD, University Hospital Düsseldorf, Düsseldorf 40225, Germany., Ruebner M; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Lehle S; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Uhrig S; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Ziegler P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Link T; Department of Gynecology and Obstetrics, Carl Gustav Carus Faculty of Medicine and University Hospital, Dresden, TU 01307, Germany.; National Center for Tumor Diseases (NCT), Dresden 01307, Germany; German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Carl Gustav Carus Faculty of Medicine and University Hospital, Dresden, TU 01307, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden 01307, Germany.; German Cancer Consortium (DKTK), Dresden 01307, Germany; German Cancer Research Center (DKFZ), Heidelberg 69120, Germany., Hack CC; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Belleville E; ClinSol GmbH & Co. KG, Würzburg 97074, Germany., Faull I; Guardant Health, Inc., Redwood City, CA 94063, USA., Hausch M; Guardant Health, Inc., Redwood City, CA 94063, USA., Wallwiener D; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen 72076, Germany., Schneeweiss A; National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany., Tesch H; Oncology Practice at Bethanien Hospital Frankfurt, Frankfurt am Main 60389, Germany., Brucker SY; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen 72076, Germany., Beckmann MW; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen 91054, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen 91054, Germany., Müller V; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg 20246, Germany., Fehm TN; Department of Gynecology and Obstetrics, CIO ABCD, University Hospital Düsseldorf, Düsseldorf 40225, Germany.
Source: Precision clinical medicine [Precis Clin Med] 2024 Dec 24; Vol. 8 (1), pp. pbae034. Date of Electronic Publication: 2024 Dec 24 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101739592 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-1571 (Electronic) Linking ISSN: 25161571 NLM ISO Abbreviation: Precis Clin Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2516-1571
DOI:10.1093/pcmedi/pbae034